Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina.
Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee.
Pharmacotherapy. 2017 Nov;37(11):1357-1365. doi: 10.1002/phar.2021. Epub 2017 Oct 17.
As delirium is a common manifestation in critically ill patients and is associated with worse clinical outcomes, we sought to characterize the reversibility of delirium after discontinuation of sedation and to determine whether sedation-associated delirium that rapidly reverses impacts clinical outcomes.
Post hoc subgroup analysis of prospectively collected data from a previously published study.
Seventy adults admitted to a medical intensive care unit (ICU) between March and July 2012 who required mechanical ventilation with continuous analgesia and/or sedation and underwent a spontaneous awakening trial (SAT).
Patients were grouped into four categories: delirium free, rapidly reversible delirium (RRD; defined as delirium always resolving within 4 hrs of stopping sedatives), persistent delirium (PD; defined as delirium always persisting for ≥ 4 hours after stopping sedatives), or mixed delirium (consisting of RRD and PD episodes). The incidence of the four delirium subtypes and their associations with clinical outcomes were evaluated. A validated, guideline-recommended, bedside delirium monitoring instrument-the Confusion Assessment Method for the ICU (CAM-ICU)-was used to assess for the presence or absence of delirium. Clinical outcomes included ventilator-free days at day 28, ICU and hospital length of stay, 28-day mortality, and patient disposition; time to first CAM-ICU becoming negative (delirium free) for a continuous 48-hour duration was also assessed. A total of 103 SATs were performed in the 70 patients. Of the 103 SATs, 28 (27.2%) were CAM-ICU negative before the SAT. Of the remaining 75 SATs, PD was present for the majority of SATs (62 [82.7%]); RRD was present after 13 (17.3%) SATs. On a patient level, 17 patients (24.3%) were always delirium free before cessation of medications for continuous sedation. Of the 53 patients with delirium before undergoing an SAT, 11 (20.8%) had RRD, 2 (3.8%) had mixed delirium, and 40 (75.5%) had PD. Proportional odds logistic regression adjusting for age, Acute Physiology and Chronic Health Evaluation II score, sepsis, and preexisting hypertension showed that patients with PD had a higher probability of longer ICU length of stay (odds ratio 4.01 [95% confidence interval 1.36-11.77], p=0.011), but those with RRD did not.
Despite the cessation of medications for continuous sedation, delirium persisted for the majority of patients and was associated with worse outcomes, which attests to the importance of strategies to minimize sedation.
谵妄是危重症患者的常见表现,与临床结局恶化相关,因此我们旨在描述镇静停止后谵妄的可逆性,并确定快速逆转的镇静相关谵妄是否会影响临床结局。
先前发表的研究中前瞻性收集数据的事后亚组分析。
2012 年 3 月至 7 月期间入住医疗重症监护病房(ICU)的 70 名成年人,这些患者需要机械通气,持续镇痛和/或镇静,并接受了自主唤醒试验(SAT)。
患者分为四组:无谵妄、快速可逆性谵妄(RRD;定义为停止镇静剂后 4 小时内谵妄始终得到解决)、持续性谵妄(PD;定义为停止镇静剂后≥4 小时谵妄始终持续)或混合性谵妄(由 RRD 和 PD 发作组成)。评估了四种谵妄亚型的发生率及其与临床结局的关系。使用经过验证的、指南推荐的床边谵妄监测工具-ICU 意识模糊评估方法(CAM-ICU)评估谵妄的存在或不存在。临床结局包括第 28 天的无呼吸机天数、ICU 和住院时间、28 天死亡率和患者去向;还评估了首次成为连续 48 小时 CAM-ICU 阴性(无谵妄)的时间。在 70 名患者中进行了 103 次 SAT。在 103 次 SAT 中,有 28 次(27.2%)在 SAT 之前 CAM-ICU 为阴性。在其余的 75 次 SAT 中,PD 占大多数 SAT(62[82.7%]);在 13 次 SAT 后出现 RRD。在患者水平上,在停止连续镇静药物治疗之前,17 名患者(24.3%)始终无谵妄。在进行 SAT 之前有谵妄的 53 名患者中,有 11 名(20.8%)患有 RRD,2 名(3.8%)患有混合性谵妄,40 名(75.5%)患有 PD。调整年龄、急性生理学和慢性健康评估 II 评分、脓毒症和既往高血压的比例优势逻辑回归表明,PD 患者 ICU 住院时间更长的可能性更高(比值比 4.01[95%置信区间 1.36-11.77],p=0.011),但 RRD 患者则没有。
尽管停止了连续镇静药物治疗,但大多数患者的谵妄仍持续存在,并与不良结局相关,这证明了采取策略来最小化镇静作用的重要性。